ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00268879
Recruitment Status : Completed
First Posted : December 23, 2005
Last Update Posted : February 15, 2008
Sponsor:
Information provided by:
Alizyme

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : January 2008
  Actual Study Completion Date : January 2008